PATENT CLAIM ANALYSIS

Application Number: 15897628
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "045000"]

Abstract:
The invention provides compositions or pharmaceutical compositions for use in inducing acquired immune lymphocytes to produce type I interferons, inhibiting proliferation of the lymphocytes, and treating diseases or conditions associated with enhanced acquired immunity. Pharmaceutical compositions for use in treating diseases or conditions associated with enhanced acquired immunity, containing a STING ligand; compositions for use in inducing T cells to produce type I interferons, containing a STING ligand; and proliferation inhibitors of acquired immune lymphocytes containing a STING ligand are provided.

Claim (Index 3):
The method according to  claim 1 , wherein the method is for prophylactically treating the disease or condition associated with enhanced acquired immunity in the subject in need thereof, and comprises administering the effective amount of the STING ligand to the subject before the onset of the disease or condition.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 2.06977
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14280667', '15109945', '15241821', '15565609', '15665378']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6561381306857513
- 35 USC 102 Novelty (BERT): 0.5103162414239428
- Combined Prediction Score: 0.6415559417595704
- Mean Citation Score: 249.86114200000003
- Max Citation Score: 258.40125
- Similarity Product: 195.50210978418588

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test